Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Haughney

Showing results (41-50 of 90) with videos related to

Pageof 9
Sort By:
Advances in Therapy|April 7, 2023
A Charter to Fundamentally Change the Role of Oral Corticosteroids in the Management of AsthmaJohn Haughney, Tonya Winders, Steve Holmes, et al.
Clinicoeconomics and Outcomes Research : CEOR|September 22, 2011
Cost-effectiveness analysis of corticosteroid inhaler devices in primary care asthma management: A real world observational studyLinda Kemp, John Haughney, Neil Barnes, et al.
Journal of Asthma and Allergy|June 24, 2011
Effectiveness of inhaler types for real-world asthma management: retrospective observational study using the GPRDDavid Price, John Haughney, Erika Sims, et al.
Respiratory Medicine|May 7, 2013
Real-life comparison of beclometasone dipropionate as an extrafine- or larger-particle formulation for asthmaDavid Price, Mike Thomas, John Haughney, et al.
NPJ Primary Care Respiratory Medicine|May 1, 2015
Preference, satisfaction and critical errors with Genuair and Breezhaler inhalers in patients with COPD: a randomised, cross-over, multicentre studySergi Pascual, Jan Feimer, Anthony De Soyza, et al.
NPJ Primary Care Respiratory Medicine|February 10, 2019
Comparison of adverse events associated with different spacers used with non-extrafine beclometasone dipropionate for asthmaSimon Wan Yau Ming, John Haughney, Dermot Ryan, et al.
Advances in Therapy|March 13, 2022
Environmental Sustainability in Respiratory Care: An Overview of the healthCARe-Based envirONmental Cost of Treatment (CARBON) ProgrammeAlex Wilkinson, Ekaterina Maslova, Christer Janson, et al.
BMC Research Notes|April 18, 2014
Case-finding of chronic obstructive pulmonary disease with questionnaire, peak flow measurements and spirometry: a cross-sectional studyBassam Mahboub, Ashraf Alzaabi, Joan B Soriano, et al.
Primary Care Respiratory Journal : Journal of the General Practice Airways Group|November 5, 2013
Clinical and cost effectiveness of switching asthma patients from fluticasone-salmeterol to extra-fine particle beclometasone-formoterol: a retrospective matched observational study of real-world patientsDavid Price, Iain Small, John Haughney, et al.
BMJ Open|February 3, 2017
Cohort profile: the Scottish Research register SHARE. A register of people interested in research participation linked to NHS data setsBrian McKinstry, Frank M Sullivan, Shobna Vasishta, et al.
Pageof 9

Showing results (41-50 of 90) with videos related to

Sort By:
Pageof 9
Advances in Therapy|April 7, 2023
A Charter to Fundamentally Change the Role of Oral Corticosteroids in the Management of AsthmaJohn Haughney, Tonya Winders, Steve Holmes, et al.
Clinicoeconomics and Outcomes Research : CEOR|September 22, 2011
Cost-effectiveness analysis of corticosteroid inhaler devices in primary care asthma management: A real world observational studyLinda Kemp, John Haughney, Neil Barnes, et al.
Journal of Asthma and Allergy|June 24, 2011
Effectiveness of inhaler types for real-world asthma management: retrospective observational study using the GPRDDavid Price, John Haughney, Erika Sims, et al.
Respiratory Medicine|May 7, 2013
Real-life comparison of beclometasone dipropionate as an extrafine- or larger-particle formulation for asthmaDavid Price, Mike Thomas, John Haughney, et al.
NPJ Primary Care Respiratory Medicine|May 1, 2015
Preference, satisfaction and critical errors with Genuair and Breezhaler inhalers in patients with COPD: a randomised, cross-over, multicentre studySergi Pascual, Jan Feimer, Anthony De Soyza, et al.
NPJ Primary Care Respiratory Medicine|February 10, 2019
Comparison of adverse events associated with different spacers used with non-extrafine beclometasone dipropionate for asthmaSimon Wan Yau Ming, John Haughney, Dermot Ryan, et al.
Advances in Therapy|March 13, 2022
Environmental Sustainability in Respiratory Care: An Overview of the healthCARe-Based envirONmental Cost of Treatment (CARBON) ProgrammeAlex Wilkinson, Ekaterina Maslova, Christer Janson, et al.
BMC Research Notes|April 18, 2014
Case-finding of chronic obstructive pulmonary disease with questionnaire, peak flow measurements and spirometry: a cross-sectional studyBassam Mahboub, Ashraf Alzaabi, Joan B Soriano, et al.
Primary Care Respiratory Journal : Journal of the General Practice Airways Group|November 5, 2013
Clinical and cost effectiveness of switching asthma patients from fluticasone-salmeterol to extra-fine particle beclometasone-formoterol: a retrospective matched observational study of real-world patientsDavid Price, Iain Small, John Haughney, et al.
BMJ Open|February 3, 2017
Cohort profile: the Scottish Research register SHARE. A register of people interested in research participation linked to NHS data setsBrian McKinstry, Frank M Sullivan, Shobna Vasishta, et al.
Pageof 9